Vol 4 (October 25, 2026): AME Clinical Trials Review

Revisiting neoadjuvant strategies in pancreatic cancer: insights from CASSANDRA

Validating IGF-1R targeted therapy for thyroid eye disease in Asian patients

Immediate or deferred non-culprit lesion pci in myocardial infarction: refining the timing of completeness

Interim insights into supplemental breast imaging for dense breasts: lessons from the BRAID trial

The role of low-dose atropine for childhood myopia: evaluating efficacy, durability and dosing

Immune priming before intravesical bacillus Calmette-Guérin in non-muscle-invasive bladder cancer: lessons and perspectives from the RUTIVAC-1 trial

ENHANCE-ing outcomes in acute myeloid leukemia through immunotherapy: are we there yet?

The use of amustaline/glutathione pathogen-reduced red blood cells in cardiac surgery: a commentary

Cyclic exclusive enteral nutrition and the nebulous diet landscape in Crohn’s disease

[¹⁷⁷Lu]Lu-PSMA-617 and PD-1 blockade: lessons from the PRINCE trial

When a procedure fails an RCT, what exactly failed?—Interpreting provider-dependent procedure trials: a narrative review